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Abstract
Profiling of protein species is important because gene polymorphisms, splice variations and post-
translational modifications may combine and give rise to multiple protein species that have 
different effects on cellular function. Two-dimensional gel electrophoresis is one of the most 
robust methods for differential analysis of protein species, but bioinformatic interrogation is 
challenging because the consequences of changes in the abundance of individual protein species 
on cell function are unknown and cannot be predicted. We conducted DIGE of soleus muscle from 
male and female rats artificially selected as either high- or low-capacity runners (HCR and LCR, 
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respectively). In total 696 protein species were resolved and LC–MS/MS identified proteins in 337 
spots. Forty protein species were differentially (P < 0.05, FDR < 10%) expressed between HCR 
and LCR and conditional independence mapping found distinct networks within these data, which 
brought insight beyond that achieved by functional annotation. Protein disulphide isomerase A3 
emerged as a key node segregating with differences in aerobic capacity and unsupervised 
bibliometric analysis highlighted further links to signal transducer and activator of transcription 3, 
which were confirmed by western blotting. Thus, conditional independence mapping is a useful 
technique for interrogating DIGE data that is capable of highlighting latent features.
Keywords
Animal Selection Model; Bibliometric network analysis; Mass spectrometry; N-myc down-
regulated gene 2; Sexual dimorphism; Signal transducer and activator of transcription 3
1. Introduction
The statistical link between exercise capacity and all-cause mortality is irrefutable [1] but the 
mechanisms that underpin the preventive effects of physical activity are not yet fully 
understood. Previously, we have used proteomic techniques to investigate adaptations in 
human skeletal muscle [2], and in the heart [3] and skeletal muscle [4] of outbred rats. 
However, it is difficult to know whether changes measured in the proteome after a period of 
exercise training reflect an acute response to the last bout of exercise or a summative chronic 
response to the increase in habitual activity. Moreover, the concurrent acute effects and 
chronic responses to exercise may be influenced by genetic factors that affect either baseline 
levels or the responsiveness to training stimuli. To minimise these complications and 
specifically investigate the link between aerobic capacity and disease risk we have used 
divergent artificial selection in a genetically heterogeneous population of rats to create two 
populations with markedly different intrinsic running capacities [5]. Early in the selection 
process it was noted [6] that low capacity runners (LCR) were insulin resistant and displayed 
cardiovascular risk factors including hypertension and dyslipidaemia. In contrast, high 
capacity runners (HCR) exhibit enhanced metabolic flexibility including augmented muscle 
glucose uptake and oxidation in the presence of insulin, as well as heightened uptake and 
oxidation of lipids under fasting conditions [7]. These differences in substrate utilisation 
between HCR and LCR are associated with greater abundance and efficiency of 
mitochondria [8] as well as enhanced insulin receptor signalling [9] in HCR animals. As 
such these findings add further associational evidence linking muscle aerobic capacity with 
metabolic disease risk, but the regulatory networks driving these phenomena remain to be 
discovered.
Transcriptome profiling of HCR/LCR muscle [10] reported 239 differentially expressed 
genes, and gene-set enrichment analysis found correlations between free-wheel running 
capacity and gene-sets including oxidative phosphorylation, fatty acid oxidation and PPAR 
signalling. Furthermore, label-free LC–MS profiling [11] provided protein-level 
confirmation for the greater abundance of heart-type fatty acid binding protein, cytochrome 
b-c1 complex subunit 1 and cytochrome c oxidase subunit 4, isoform 1 in HCR skeletal 
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muscle. Nonetheless, divergence between HCR and LCR populations is likely to involve 
complex epistatic interactions and additive selection of genes consisting of different alleles, 
which may create differences at the protein-species level [12]. Proteome mining studies (e.g. 
[13,14]) have used sophisticated orthogonal separations and LC–MS/MS analysis to 
catalogue approximately 2000 of the most abundant muscle proteins. However, it is not 
possible to analyse large numbers of protein species (also known as ‘proteoforms’ [15]) 
using these techniques. This is because tryptic digestion severs the link between the different 
combinations of post-translational modifications that make up each species. In contrast, 
protein species can be readily resolved using 2D gel electrophoresis based on differences in 
isoelectric point (pI) and relative mass (Mr) [4,16]. Indeed, using 2D difference in-gel 
electrophoresis (DIGE) we [17] discovered the first evidence that the cardiac proteome of 
LCR is exposed to greater oxidative stress, based on modification of metabolic enzymes by 
the cytotoxic aldehyde, 4-hydroxynonenal (4-HNE). Our DIGE analysis resolved almost 
1000 cardiac protein species but it was difficult to exploit this highly parallel data using 
mainstream bioinformatic tools that assume greater abundance of transcripts or proteins can 
be inferred to mean a greater contribution to cellular function. For example, an increase in 
the density of a 2Dgel spot may in some cases depict a greater abundance of a relatively 
inactive species of that protein and hence a decrease in the related cellular function. Because 
we do not know the entire proteome and are unable to predict the role of each species of a 
protein, pragmatic methods for finding associations between protein species are needed that 
do not rely on prior knowledge. In particular, it is important to seek ‘un-biased’ or 
unsupervised approaches because our intuitive interpretations are not objective and are 
influenced strongly by our perception of which proteins/events/pathways etc. are of greatest 
importance in particular scenarios.
Proteins interact with each other physically or through contribution to mutual processes (e.g. 
oxidative phosphorylation) so many complex associations exist within proteome data. If key 
nodes within these networks could be identified objectively this would direct the integration 
of knowledge to focus attention to pertinent avenues of research. Previously, unsupervised 
techniques including principal component analysis, hierarchal clustering or self organising 
maps (k-means clustering) have been used to group together proteins that share similar 
patterns of expression across biological replicates or experimental cases (e.g. [18]). This 
approach to finding shared patterns of expression can be useful but the fact that proteins 
cluster together does not provide evidence that they are components of the same network or 
that they share dependent relationships. In contrast, conditional independence maps can be 
used to find networks within complex data based on multivariate associations between nodes 
(in this case, protein species). Herein we use the CImap package [19] which is a constraint-
based approach to discovering multivariate association networks and is used to create a 
directed acyclic graph of associations within the data. Conceptually, this approach is 
perfectly matched to the task of interrogating data from techniques such as DIGE, which 
create highly-detailed parallel information that might reasonably be expected to depict 
functional, but unknown, associations between protein species.
The current work focuses specifically on skeletal muscle responses to artificial selection on 
running capacity. Previous studies (e.g. [7]) report the greatest differences in muscle 
metabolism between HCR and LCR are evident in fast-twitch and mixed-fibre muscles, such 
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as the gastrocnemius. However, the proportion of type IIa/x fibres in gastrocnemius of HCR 
rats (42 ± 16%) is approximately double (P < 0.01) that (22 ± 14%) of LCR animals [10], 
and this difference in myofibre profile probably contributes to the differences in muscle 
metabolism. Here, we investigate whether differences in metabolism between HCR and LCR 
are evident in the soleus muscle which has a similar myofibre profile in HCR and LCR 
animals [10]. Of equal importance, the aforementioned literature is based on data from 
female HCR/LCR animals only. Muscle of females may have a greater capacity for fatty 
acid metabolism than male muscle [20], therefore, differences in HCR and LCR metabolism 
might be exaggerated or skewed when studied in an entirely female population. Indeed, just 
3 studies [21–23] report skeletal muscle analysis of HCR/LCR males. Moreover, few 
proteomic studies have addressed the issue of sexual-dimorphism in skeletal muscle. 
Preliminary data suggest that sex-specific responses may occur in muscle of rats exposed to 
high-fat diet [24] and streptozotocin administration [25] but these comparisons on pooled 
samples preclude statistical analysis and interpretation relative to biological variability. 
Metskas et al. [26] report sex-specific differences in the biceps brachii proteome of mice, 
including greater abundances of creatine kinase, glycolytic enzymes and components of the 
pyruvate dehydrogenase complex in males, whereas myoglobin and electron transfer protein 
alpha were more abundant in females. These findings seem consistent with the reported [27] 
effects of oestrogen on muscle metabolism but fall short of providing clear evidence of gross 
differences in mitochondrial density or lipid oxidation. Nonetheless, these limited data raise 
the issue of whether literature reporting differences in HCR/LCR muscle metabolism are 
biased by the disproportionate use of female animals, including potential underreporting of 
paternal traits.
2. Materials and methods
2.1. Animal model
The inception of HCR-LCR strains from a founder population of genetically heterogeneous 
N:NIH rats has been described in detail [5]. Thirty-two male and female HCR/LCR rats (n = 
8, in each group) from generation 25 (12–13 weeks old) were imported from the University 
of Michigan. The transfer of animals to the UK and subsequent procedures were conducted 
under the British Home Office Animals (Scientific Procedures) Act 1986 and according to 
UK Home Office Guidelines. Rats were housed in a conventional facility and the 
environmental conditions controlled at 20 ± 2 °C, 45–50% relative humidity with a 12 h 
light (0600–1800) and dark cycle. Food and water were available ab libitum during a 14-day 
acclimatization period. After an overnight fast, animals were asphyxiated with CO2 and 
killed by cervical dislocation. Blood was collected by cardiac puncture and allowed to clot at 
room temperature prior to being placed on ice overnight. After centrifugation, serum 
fractions were stored at −80 °C and later analysed by ELISA for leptin (Millipore, Billerica, 
MA). Skeletal muscles and other organs were isolated and cleaned of fat and connective 
tissue before being weighed. In preparation for histochemical analysis, a segment of the 
mid-belly of each skeletal muscle was resected and mounted in transverse section before 
being snap-frozen in supercooled isopentane. Counter lateral muscles were frozen in liquid 
nitrogen in preparation for proteomic analyses.
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2.2. Histochemical analysis of muscle phenotype
Serial cryosections (5 μm thick) were cut from soleus muscle specimens and stained using 
nicotinamide dinucleotidetetrazolium reductase (NADH-TR) or periodic acid-Schiff (PAS) 
techniques, described in [28]. Myofibre types were determined based on anti-MyHC type I 
and IIa (1:10 dilution, N2.261; Axxora) and anti-MyHC type IIa and IIx (1:50 dilution, 
N3.36; Santa Cruz) Ab staining. Primary Ab was detected with HRP-conjugated secondary 
Ab (1:100 dilution) and visualised using a DAB and counterstained with haematoxylin. 
Cryosections were viewed (100 magnification) by light microscopy and were digitised using 
a 12-bit charge-coupled device (1213C; DVC, Austin, Texas). One hundred myofibres from 
each muscle were randomly selected and identified as being either type I, type IIa or type 
IIx/b. Calibrated image analysis software (Lucia; LIM, Hostivar, Czech Republic) was used 
to measure myofibre cross-sectional area (CSA), and the average mitochondrial density and 
glycogen content were estimated by measuring the optical density of type I, IIa, or IIx/b 
fibres (100 each) on NADH-TR or PAS-stained cryosections, respectively.
2.3. DIGE of soluble muscle proteins
Soleus muscles were pulverised in liquid nitrogen then homogenised on ice in 8 volumes of 
1% Triton X-100, 50 mM Tris pH 7.4 containing Complete™ protease and PhosSTOP 
phosphatase inhibitors (Roche Diagnostics, Lewes, UK). Samples were incubated on ice for 
10 min then centrifuged at 12,000 rcf, 4 °C for 45 min. Supernates were precipitated in 
acetone and resuspended in lysis buffer: 7 M urea, 2 M thiourea, 4% (w/v) CHAPS, 30 mM 
Tris, containing protease and phosphatase inhibitors. Protein concentrations were measured 
using the Bradford assay (Sigma, Poole, Dorset, UK) and each sample adjusted to 5 μg μl−1 
in either Lysis buffer for DIGE analysis or Laemmli buffer for western blot analyses.
Fifty microgram aliquots of each sample and the pooled internal standard were labelled with 
400 pM CyDye DIGE Fluor minimal dyes (GE Healthcare, Little Chalfont, UK), consistent 
with previous work [17]. To minimise the potential confounding effects of differences in 
fluorescence intensity, Cy3 and Cy5, labelling was alternated between LCR and HCR 
samples in a ‘balanced’ design. Labelled LCR and HCR aliquots and pooled Cy2-labelled 
standard were combined with rehydration buffer: 7 M urea, 2 M thiourea, 2% (w/v) CHAPS, 
20 mM DTT and 0.5% (v/v) ampholytes. IPG strips (24 cm pH 3– 10 non-linear; 
Immobiline Drystrip, GE Healthcare) were rehydrated overnight in 450 μl rehydration buffer 
that contained the combined cyanine-labelled samples. Isoelectric focusing (maximum 50 
μA per strip) was performed on an IPGPhor II (GE Healthcare) at 20 °C using the protocol 
(total 44000 Vh): 3 h at 300 V, 3 h at 600 V, 3 h at 1000 V, gradient to 8000 V in 3 h and 
then 4 h at 8000 V. IPG strips were equilibrated in 50 mM Tris–HCl pH 8.8, containing 6 M 
urea, 70 mM SDS, 30% v/v glycerol and a trace amount of bromophenol blue. DTT (65 
mM) was present in the first equilibration and iodoacetamide (135 mM) in the second. 
Proteins were electrophoresed (Ettan Dalt six; GE Healthcare) through denaturing 12.5% 
poly-acrylamide gels at 20 °C; at 5 W per gel for 30 min, then 17 W per gel until the 
tracking dye reached the bottom edge.
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2.4. Difference profiling and statistical analyses
Gels were digitised (16-bit greyscale, 100 μm pixel size) immediately after electrophoresis 
using a fluorescence scanner (Typhoon 9400, GE Healthcare) at wavelengths appropriate for 
Cy2, Cy3 and Cy5 dyes. Gel images (Cy2, Cy3 and Cy5, total = 30) were aligned in 
SameSpots (Nonlinear Dynamics, Newcastle, UK) using prominent spots (mean ± SD per 
gel image: 548 ± 36) as vectors to warp each image to a common reference gel. A mask was 
used to remove gel artefacts (109 spots deleted) and features with an average normalised 
volume < 10,000 (147 spots) or spot area < 150 (33 spots) were disregarded. In total, 696 
spots were included in the subsequent analysis. As a measure of technical variation, when 
ranked by coefficient of variation, 70% of spots in Cy2 images (pooled standard) had a 
coefficient of variation less than 14%. Log transformed spot volumes, expressed relative to 
the pooled standard, were exported to PASW Statistics software (IBM, Portsmouth, UK) and 
used to investigate differences in expression due to sex (male versus female) and strain (LCR 
versus HCR) by two-way analysis of variance. To control false discovery rate (FDR), P-
value distributions were used to calculate q-values [29] and a criterion FDR of <10% was 
set. This statistical approach considers the biological variation across each spot and is, 
therefore, more sophisticated than arbitrarily implementing a threshold based on fold-
change.
2.5. Identification of gel spots using nLC-ESI-MS/MS
Proteins were identified from colloidal Coomassie-stained (Bio-Safe; Bio-Rad, Hercules, 
CA, USA) preparative gels loaded with 1.5 mg protein (pooled standard). A batch of 384 
spots was cut and processed using a Xcise robot (Shimadzu Biotech) directed by a picking 
list produced from the SameSpots analysis. In addition, spots adjacent to differentially 
expressed proteins were also excised to investigate the presence of different species of these 
proteins. In-gel tryptic digestion was conducted in 96-well microtitre plates as described 
previously [4] and the reaction was terminated by the addition of formic acid to a final 
concentration of 0.1%. Tandem mass spectra were recorded using a quadrupole-high 
capacity ion-trap (HCT Ultra ETD II; Bruker Daltonics, Bremen, Germany) coupled via an 
electrospray ionisation source to a nano-flow HPLC system (Ultimate 3000; Dionex, 
Sunnyvale, CA). Samples (10 μl in-gel digest) were loaded in aqueous 0.1% (v/v) formic 
acid via a Zorbax 300SB-C18, 5 μm, 5 mm × 300 μm pre-column (Agilent Technology, 
Santa Carla, CA). Separation was conducted at 30 °C through a Zorbax 300SB-C18, 3.5 μm, 
150 mm × 75 μm analytical reverse phase column (Agilent Technology). Peptides were 
eluted using a gradient rising to 40% acetonitrile 0.1% (v/v) formic acid over 30 min at a 
flow rate of 300 nl/min. An online nanospray source (EasyNano, Bruker Daltonics) was used 
equipped with a fused silica emitter. The capillary voltage was −1300 V and a survey scan 
from 350 m/z to 1600 m/z was used to select peptides with charge states of +2 or +3 using 
Enhanced Scan mode (8100 (m/z)/s). Data dependent MS/MS analysis in alternating CID 
and ETD modes was performed selecting the two most abundant precursor ions with active 
exclusion enabled. Raw data were processed (Data Analysis 4.0, Bruker Daltonics) and 
Mascot generic format files were searched against the Swiss-Prot database (2011.6) 
restricted to ‘Rattus’ (7617 sequences) using a locally implemented Mascot 
(www.matrixscience.com) server (version 2.2.03). A first round Mascot error tolerant search 
and subsequent directed searches were performed using a bioinformatic platform 
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(ProteinScape, Bruker Daltonics). The enzyme specificity was trypsin allowing 1 missed 
cleavage, carbamidomethyl modification of cysteine (fixed), oxidation of methionine 
(variable) and an m/z error of ± 0.5 Da. The directed searches also included acetylation of 
lysine and phosphorylation of serine, threonine or tyrosine residues as possible 
modifications.
2.6. Bioinformatic analyses
Functional enrichment analysis was conducted using the Database for Annotation, 
Visualization and Integrated Discovery [DAVID; http://david.abcc.ncifcrf.gov/home.jsp 
[30]]. The non-redundant lists of differentially expressed proteins (FDR < 10% for each 
main effect: sex and strain) were investigated for over-representation of gene ontology (GO) 
classes: cellular component (CC), biological process (BP) and molecular function (MF). 
Association of proteins with pathways of the Kyoto Encyclopedia of Genes and Genomes 
[KEGG; http://www.genome.jp/kegg/ [31]] was also assessed, and the statistical significance 
of clusters was estimated by modified Fisher exact P value.
Conditional independence mapping was used to graph interrelations within the population of 
spots that were significantly (FDR < 10%) differentially expressed due to HCR/LCR strain. 
Data were analysed in MatLab using the CImap package [19] to create conditional 
independence maps that describe multivariate association networks within the data. Log-
transformed continuous data of spot expression were converted to categorical terciles or 
quintiles to assess course- and fine-grain associations, respectively. Each analysis began with 
a fully-connected undirected graph and conditional independence tests were used to 
determine whether edges (associations) between vertices (protein spots) should be kept or 
deleted. These decisions were made using conditional mutual information, which is an 
estimate of association strength that is approximated by the chi-squared distribution. That is, 
decisions regarding inclusion or exclusion of edges were made by performing chi-squared 
tests on the null hypothesis that two vertices are independent. This process was ordered so as 
to test and exclude weak edges first and arrive at a directed acyclic graph that depicts the 
multivariate association network within the data. CImap also includes computational 
procedures for bounding the false positive and false negative rates, to enable conditional 
independence testing within small sample sizes. To construct the tercile map α was set at 
0.05, whereas more stringent (α = 0.01) testing was used in the construction of the quintile 
map. Post-hoc pair-wise testing was used to approximate the relative strength of associations 
between vertices in order to dictate edge length (shorter edge = stronger association) during 
the construction of each map.
Bibliometric network mapping was conducted using iHOP (http://www.ihop-net.org; [32]). 
Gene models were constructed from evidence in the rat, human and mouse interaction pages 
for the protein of interest. Information was manually curated and filtered to include evidence 
of co-expression, co-localisation, protein–protein interaction and modulation by gain/loss of 
function interventions.
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2.7. Western blotting
Samples in Laemmeli buffer [33] were heat denatured (5 min at 95 °C) and aliquots 
containing 50 μg protein were loaded on precast 4–20% polyacrylamide gels (Precise Tris–
HEPES protein gels; Thermo Scientific). Electrophoresis was conducted at 80 V for 20 min 
then 140 V for 40 min using a mini-gel system (MiniVE; GE Healthcare, Little Chalfont, 
UK). Electro-transfer of proteins to methanol-activated polyvinylidene difluoride 
membranes was conducted in Towbin buffer [34] at 25 V for 2 h. Successful transfer was 
confirmed by staining membranes with direct blue 71, according to [35]. Non-specific 
protein interactions were blocked by incubating the membranes with 5% non-fat dry milk in 
20 mM Tris, 150 mM NaCl, and 0.1% Tween 20, pH 7.6 (TBS-T) for 1 h at room 
temperature. Membranes were then washed in TBS-T and incubated overnight with TBS-T 
containing 5% BSA and primary antibodies specific for: signal transducer and activator of 
transcription 3 (STAT3; 9139 Cell Signalling Technology; 1:5,000 dilution) and 
phosphorylated (S727 or Y705) STAT3 (9134 and 9131, Cell Signalling Technology; 1:500 
dilution). Serial washes in TBS-T were performed prior to enhanced chemiluminescence 
(ECL Prime; GE Healthcare) and digitization (Gel Doc XRS; Bio-Rad, Hercules, CA) of 
immuno-reactive protein bands. Image analysis (Quantity One, version 4.; Bio-Rad) was 
used to measure the relative abundances of target proteins. Analysis of phosphorylated and 
non-phosphorylated species was achieved by stripping and re-probing of membranes. 
Briefly, membranes were stripped by incubation in 62.5 mM Tris, 70 mM SDS, 50 mM β-
mercaptoethanol, pH 6.8 at 50 °C for 30 min. Successful removal of the immuno-signal was 
assessed by enhanced chemiluminescence prior to subsequent immuno-detection.
3. Results
3.1. Physical and physiological characteristics
The physical characteristics of male and female HCR and LCR rats are displayed in Table 1. 
In females, body weight of LCR was 1.26-fold greater than HCR, and the body weight of 
males was 1.38-fold greater in LCR compared to HCR. There was a statistically significant 
interaction in distance completed during a standardised exercise test. HCR females ran 
significantly further than any other group and the difference in running capacity between 
HCR and LCR strains was 5.87-fold in females and 6.44-fold in males. Hence, regardless of 
strain, females were lighter and ran further than males and this corresponded with significant 
differences in work (J) performed during the exercise test. Consistent with the smaller body 
mass of females the wet weight of the heart and skeletal muscles was significantly less in 
females compared to males. Similarly, absolute wet weights of heart and red gastrocnemius 
muscle were significantly less in HCR (i.e. consistent with the differences in body weight), 
but there was no significant difference in the average wet weights of soleus, EDL and tibialis 
anterior muscle between HCR and LCR strains.
3.2. Soleus muscle phenotype
Soleus had type I (~20%) and type IIa (~80%) myofibres only and there was no significant 
difference in the portions of these fibres between male and female HCR and LCR. The CSA 
of type I and IIa fibres was greater in male than female, this was statistically significant for 
type IIa fibres and consistent with the greater soleus mass in males compared to females. 
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The area fractions of type I and type IIa were not different in male and female HCR and 
LCR soleus (Table 2). Mitochondrial density (NADH-TR staining) of both type I and type 
IIa fibres was significantly greater in HCR than LCR. No significant differences were 
detected in myofibre glycogen content (PAS staining).
3.3. Proteome mining of soluble skeletal muscle proteins
Mass spectrometry of selected 2D gel spots unambiguously identified proteins in 337 spots 
and generated a non-redundant list of 154 gene products. A detailed 2D gel map of the 
proteins identified by mass spectrometry is available in the World 2D-PAGE repository 
(http://world-2dpage.expasy.org/repository/), accession number 0069. This resource displays 
the position and Swiss-Prot database identification of each gel spot. The spot reference 
numbers used in this article are also displayed and each identified spot is linked to the raw 
CID and ETD MS/MS spectra in Mascot Generic Format (.mgf).
Based on the outcomes of Mascot error tolerant searches, directed MS/MS ion searches were 
performed with phosphorylation (S/T and Y) and acetylation (K) as possible modifications. 
Manual verification of fragment-ion sequence ladders in peptides with scores >20 created a 
list of 70 peptides from 29 gel spots, which encompassed 19 non-redundant gene products 
(Supplementary Table S1). Of the 70 modified peptides, 59 have been previously reported 
and 11 were novel modifications not currently recorded in PhosphoSite 
(www.phosphosite.org). In the majority, potential sites of modification were supported by 
CID spectra only, which may be a consequence of the relatively short LC gradient, arbitrary 
ordering of CID before ETD fragmentation or the preference of ETD fragmentation for 
higher charge-state precursors. Five spots (411, 419, 427, 431, 433) each identified as N-
myc down-regulated gene 2 (NDRG2) protein, exhibited CID evidence of numerous S/T 
phosphorylation sites. In each of the NDRG2 spots, CID and ETD fragment spectrum pairs 
for a peptide spanning residues 328–343 and indicating phosphorylation of serine 228, 230 
or 332 were recorded during the proteome mining exercise.
3.4. DIGE profiling of male and female, HCR and LCR soleus
Two-way analysis of variance performed on the 696 gel spots matched in male and female 
soleus muscle of HCR and LCR rats detected 15 spots that were significantly (P < 0.05, 
FDR < 10%) different between males and females (Table 3) and 40 spots that were 
significantly (P < 0.05, FDR < 10%) different between HCR and LCR strains (Table 4). An 
image of the 2D reference gel annotated with the position of each of the statistically 
different protein spots is shown in Fig. 1. Overlap of spots that were different between 
HCR/LCR strain and those different between sexes was limited to 4 spots (#53 HSP7C, 
#139 SPA3K, #165 ODP2 and #379 ENOB) and just one spot (#379, β-enolase) exhibited a 
statistically significant interaction (more abundant in male LCR). β-Enolase is a highly 
abundant glycolytic enzyme and was resolved into 9 spots that had different pI but similar 
Mr. This spot pattern may reflect different states of modification. β-Enolase can undergo S, 
T and Y phosphorylation and K acetylation but proteome mining did not identify post-
translational modifications specific to spot #379. Moreover, the 1.06-fold greater abundance 
of spot #379 specific to male LCR was somewhat overshadowed by the 2.57-fold greater 
abundance of β-enolase spot #410 that was observed in both male and female LCR (Table 4). 
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Considering the wider effects on metabolic enzymes (Fig. 2), the greater abundance of β-
enolase likely reflects a shift toward greater reliance on glycolytic metabolism in LCR 
muscle.
Functional annotation linked the non-redundant protein identifications with several GO 
classes and KEGG pathways. Proteins more abundant in HCR (total 25 non-redundant gene 
products) linked with mitochondria (CC), generation of precursor metabolites (BP), 
nucleotide binding (MF) and were associated with TCA Cycle and Ox Phos KEGG 
pathways (Fig. 2). Proteins more abundant in LCR (total 7 non-redundant gene products) 
linked with serine-type endopeptidase inhibitor activity (MF) and were associated with the 
Glycolysis KEGG pathway. The main sex-specific difference was the enrichment of 
cytosolic proteins (CC) linked with the response to oxidative stress (BP) and chaperone 
binding (MF) in males (total 8 non-redundant gene products). The 7 non-redundant gene 
products that were more abundant in females did not exhibit significant enrichment of GO or 
KEGG classifications.
Conditional independence maps of course- and fine-grain associations within the DIGE data 
were complementary with the functional enrichment analysis and also highlighted important 
additional information. Course-grain mapping (Fig. 3A) based on significant (α = 0.05) 
associations found using tercile categorisation of the data highlighted 3 clusters focusing on 
60 kDa heat shock protein (CH60; spot #328), protein disulphide isomerase A3 (PDIA3; 
spot #210) and hypoxanthine–guanine phosphoribosyltransferase (HPRT; spot #757). The 
cluster centred on CH60 primarily consisted of mitochondrial proteins, which is consistent 
with the functional enrichment analysis and the key role of CH60 in mitochondrial protein 
import. A second PDIA3 spot (#206) linked the two principal clusters of CH60/spot #238 
and PDIA3/spot #210. Thus protein species of PDIA3 were connected with a large number 
of the differentially regulated proteins and may also provide a link to the different 
mitochondrial and aerobic capacities of HCR and LCR muscle. PDIA3 (spot #210) became 
the most prominent feature when more stringent (α = 0.01) conditional independence 
mapping was performed on quintile categorised data (Fig. 3B) but the link with theCH60was 
broken. The PDIA3 cluster included, amongst others, PDIA3 spot (#206) and serine protease 
inhibitor A3K (spot #539), which was the spot exhibiting the greatest difference (3.18-fold) 
between HCR and LCR muscle. Post-hoc testing revealed that the strongest associations 
with PDIA3 spot #210 wereNDRG2 (spot #433; K = 1.1761), fumarate hydratase (FUMH, 
spot #426; K = 1.1761) and very long-chain acetyl CoA dehydrogenase (ACADV, spot #65; 
K = 1.1573).
Proteome mining showed that PDIA3 was resolved as a total of 4 gel spots, and 3 of the 
protein species were differentially expressed between HCR and LCR (Table 4). Spot #206 
and #220 were more abundant in LCR whereas spot #210 was greater in HCR, which 
indicate a shift in post-translational state. Routine mass spectrometry analysis conducted 
during the proteome mining exercise identified potential phosphorylation of S176 in PDIA3 
spot #210 (see Supplementary data).
A bibliometric network was constructed as an unbiased means to explore literature evidence 
of proteins that have been associated with PDIA3 (Fig. 4). The majority of citations were 
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related to protein–protein interactions between PDIA3 and the ER chaperones calnexin and 
calreticulin. Second to these interactions was strong evidence of the association of PDIA3 
with the signal transducer and activator of transcription 3 (STAT3), which encompassed 
evidence from co-expression, co-localisation, protein–protein interaction and gain/loss of 
function studies.
3.5. Western blot analysis of STAT3
The abundance of STAT3 protein was not significantly different between male and female or 
HCR and LCR soleus muscles (Fig. 5). Similarly, there was no significant difference in the 
relative ratio of tyrosine (Y705) phosphorylation of STAT3. However, serine (S727) 
phosphorylation of STAT3 was 1.54-fold greater (P = 0.0058) in LCR soleus.
3.6. Serum leptin levels
STAT3 is a canonical component of skeletal muscle leptin signalling and differences in 
serum leptin levels in HCR/LCR animals have been reported [36]. There were significant (P 
< 0.05) sex-specific and strain-specific differences in serum leptin concentrations. Values in 
males (M-HCR = 2.92 ± 1.56 ng·ml−1; M-LCR = 5.71 ± 2.59 ng·ml−1) were greater than 
values in females (F-HCR = 1.07 ± 0.46 ng·ml−1; F-LCR = 2.76 ± 0.71 ng·ml−1) but there 
was no statistically significant interaction between sex and strain. Further to differences 
between HCR and LCR group means, significant correlation was found between individual 
serum leptin concentrations in LCR and the abundance of 60 kDa heat shock protein (spot 
#238: R2 = 0.238, P = 0.029), stress-70 protein (spot #107: R2 = 0.415, P = 0.0022), serine 
protease inhibitor A3K (spot #123: R2 = 0.392, P = 0.0031 and Spot #139: R2 = 0.4915, P = 
0.0006), β-enolase (spot #379: R2 = 0.2668, P = 0.0197 and spot #341: R2 = 0.227, P = 
0.034), enoyl-CoA hydratase (spot #762: R2 = 0.204, P = 0.046) and fumarate hydratase 
(spot #423: R2 = 0.211, P = 0.042 and spot #426: R2 = 0.266, P = 0.02).
4. Discussion
DIGE analysis revealed that there is little or no sexual dimorphism in the muscle response to 
artificial selection on running capacity. Significant main effects of sex (15 spots) and strain 
(40 spots) were clearly evident in the soleus proteome but just 1 spot (#379; β-enolase) 
exhibited a statistically significant sex strain interaction. As anticipated, the myofibre profile 
was identical in HCR and LCR soleus and HCR muscle exhibited significantly greater 
mitochondrial content (Table 2). Indeed, the majority of differences between the HCR and 
LCR soleus proteomes were of mitochondrial origin, which support recent hypothesis-led 
studies [8,37] and our preliminary proteome profiling [11] using label-free LC–MS. 
Furthermore, our current DIGE analysis highlighted mitochondrial protein import as a 
potential mechanism underpinning the enhanced mitochondrial function in HCR muscle.
Further to the conventional analysis of the DIGE data, we used conditional independence 
mapping as an objective means to identify associations between protein species that 
exhibited significant differences in abundance (Fig. 3). This novel approach highlighted 
important interactions, which were not obvious from first-principle deduction of gene 
ontology annotations. The 2most prominent networks highlighted by conditional 
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independence mapping centred on protein disulphide isomerase A3 (PDIA3; spot #210) and 
60 kDa heat shock protein (CH60; spot #238). This places particular emphasis on these 
proteins as candidate biomarkers and potential mediators of the differences between HCR 
and LCR skeletal muscle.
4.1. PDIA3 species are associated with STAT3 signalling
PDIA3, also known as endoplasmic reticulum protein 57 (ERp57) or glucose-responsive 
protein58 (GRP58), was first described as a thiol-dependent reductase [38,39]. However, 
silencing of PDIA3 does not have major effects on ER morphology or processes such as the 
unfolded protein response, but instead significantly affects STAT3 signalling [40]. 
Accordingly, PDIA3 and STAT3 are reported to interact in a ~200–400 kDa ‘statosome’, 
which is capable of influencing cytokine (IL-6) signalling in hepatoma (Hep3B) cells [41]. 
In fibroblasts, the protein abundance, Y705 phosphorylation and transcriptional activity of 
STAT3 are augmented in the absence of PDIA3 and this effect is reversed by transfection 
with PDIA3 directed to the ER lumen [40]. Changes in the abundance of PDIA3 have been 
reported due to ageing or exercise. PDIA3 is more abundant in the gastrocnemius of elderly 
compared to young rats [42], and endurance training is associated with an increase in PDIA3 
abundance in human muscle mitochondria [43]. However, the current DIGE data depicts 
changes across different species of PDIA3 rather than differences in total abundance.
We resolved PDIA3 as 4 spots (220, 206, 210 and 202) of equivalent Mr but different pI 
indicating different protein species, which may be due to post-translational modifications or 
sequence variations. A similar PDIA3 spot pattern has been reported in hepatic tissue [44], 
where some PDIA3 species exhibited diurnal fluctuations. PDIA3 spot 4 and spot 3 reported 
in [44] were found to contain phosphorylated (S150) PDIA3 and probably correspond to 
spots 220 and 206 of current DIGE map, which were more abundant in LCR muscle. Our 
proteome mining work failed to unambiguously identify site-specific phosphorylations of 
PDIA3 but Kita et al. [44] used a phosphorylation specific Ab to show that S150 
phosphorylation of PDIA3 occurs in response to periods of fasting greater than 12 h [44]. In 
our experiment rats were fasted overnight (~12 h) so the significant differences in muscle 
PDIA3 spot pattern (Table 4) may also be a response to fasting. Nevertheless, the period of 
fasting was standardised across male and female, HCR and LCR groups, meaning LCR 
exhibit a greater response than HCR to an equivalent metabolic stress. Kita et al. [44] report 
that native species of PDIA3 co-precipitate with STAT3 whereas S150 phosphorylation of 
PDIA3 blocks this interaction. If S150 phosphorylation of PDIA3 is also greater in LCR 
soleus then selection on low running capacity might be associated with greater STAT3 
signalling. In support of this suggestion, the STAT3 pathway was the most highly-enriched 
gene-set in LCR gastrocnemius [10], and unsupervised bibliometric analysis highlighted 
robust connection between STAT3 and PDIA3 (Fig. 4). Using western blotting (Fig. 5), we 
found no differences in STAT3 protein abundance or Y705 phosphorylation but S727 
phosphorylation of STAT3 was greater in LCR soleus.
The canonical STAT3 pathway is activated by cytokine receptors (e.g. leptin and IL-6) and 
involves tyrosine (Y705) phosphorylation of STAT3 by Janus kinases [45]. Tyrosine 
phosphorylation enables homo-dimerisation and nuclear translocation of STAT3, whereas 
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serine (S727) phosphorylation of STAT3 disrupts this process [46]. S727 phosphorylation may 
be mediated by ERK-family mitogen activated protein kinases or ERK-independent 
processes involving the mammalian target of rapamycin (mTOR). Interestingly mTOR was 
one of the genes listed in the STAT3 pathway enriched in LCR muscle transcriptome [10]. 
Moreover, PDIA3 also interacts with mTOR and may be mechanistically involved in the 
activation of mTOR by oxidants such as phenylarsine oxide [47]. Phosphorylation of Akt 
S473 by mTOR is prevented when cells are incubated with a 2-fold excess of amino acids. 
This effect co-occurs with S727 phosphorylation of STAT3 while deletion of STAT3 
abolishes the inhibitory effects of amino acids on insulin signalling. Using a STAT3 reporter 
assay, [48] reports that amino acid excess increases the transcriptional activity of STAT3 and 
leads to greater expression of SOCS3, which may inhibit insulin signalling. These effects in 
hepatocytes could also be seen in muscle and adipose cells, therefore, S727 phosphorylation 
of STAT3 in LCR soleus may contribute to the greater insulin resistance of LCR animals and 
warrant further investigation.
Amongst other proteins in the PDIA3 cluster were serine protease inhibitor A3L (Serpin; 
Spot #539), which has a STAT3 site in its promoter and exhibited the most prominent 
increase (3.18-fold greater) in LCR muscle, and N-myc down regulated gene 2 (NDRG2; 
spot #433), which is reported to modulate STAT3 and SOCS3 responses to cytokine 
stimulation in U937 lymphoblasts [49]. NDRG2 has previously been associated with 
modulation of insulin signalling [50] and can be phosphorylated at T330, S332 and T348 by 
serum- and glucocorticoid-induced kinase 1 (SGK1) [51], at S332 by PKCθ and at T348 by 
Akt [50]. Evidence of phosphorylation at each of these sites was detected during proteome 
mining but it was not possible to distinguish spots wherein phosphorylation patterns were 
specific to an individual kinase. Nevertheless, interrogation of CID and ETD spectra revelled 
spots #431 and #433, which were more abundant in LCR, lacked any evidence of 
phosphorylation at S338, which is a commonly reported modification to NDRG2 (131 MS 
reports in PhosphoSite) that was present in the other NDRG2 spots. Currently no empirical 
evidence of an upstream kinase exists but NetPhosK predicted casein kinase 1 (CK1) may 
target S338 of NDRG2. CK1 has been implicated with metabolic circadian rhythms via its 
modulation of the degradation rate of PGC-1α [52]. Therefore, greater phosphorylation of 
NDRG2 S338 may be consistent with the lesser mitochondrial content or greater response to 
fasting in LCR.
Fumarate hydratase was also a prominent component of the PDIA3 cluster (Fig. 2B), and 
was resolved as 3 spots that were significantly less abundant in LCR muscle (Table 4). The 
lesser overall abundance of fumarate hydratase provides protein-level confirmation of earlier 
transcriptome data [10] and may point to alterations in amino acid or purine metabolism. 
Fumarate hydratase is an anaplerotic entry point for phenylalanine and tyrosine to the TCA 
cycle and is also associated with purine metabolism [53]. Accordingly we found that several 
other enzymes of purine metabolism were less abundant in LCR, including 3-
mercaptopyruvate sulfurtransferase and hypoxanthine– guanine phosphoribosyltransferase. 
Alongside its role in purine metabolism, 3-mercaptopyruvate sulfurtransferase performs the 
final reaction in the metabolism of glycine, serine and threonine to produce pyruvate. A 
lesser capacity for purine metabolism could negatively effect muscle energy regulation. In 
addition, severe fumarase deficiency may inhibit fatty acid oxidation due to inadequate 
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production of oxaloacetone, which is required to accept acetyl-CoA in to the TCA cycle. 
This latter effect seems consistent with the lesser abundance of ACADV and enoyl-CoA 
hydratase, which were also clustered with PDIA3 spot #210 (Fig. 2B).
4.2. CH60 is a key node for mitochondrial proteins
The second most prominent cluster is centred on 60 kDa heat shock protein (spot #238). 
This finding likely relates to the differences in mitochondrial content between HCR and 
LCR muscle, which are widely acknowledged. The mitochondrial proteome encompasses 
approximately 1000 known proteins [54], many of which have been described in proteome 
mining studies of muscle mitochondria (e.g. [55]). The majority of mitochondrial proteins 
are transcribed from nuclear genes whereas 13 are derived from mitochondrial DNA [56]. 
Nuclear-encoded proteins often contain target sequences to direct the pre-protein to 
mitochondria. This process is mediated by cytosolic chaperones including heat shock 
cognate 71 kDa protein [57], which was more abundant in HCR soleus. Chaperone binding 
prevents aggregation of the precursor and facilitates its recognition by the translocase of the 
outer membrane (TOM), which is the first step in mitochondrial protein import. Proteins 
destined for the mitochondrial matrix must also transverse the inner membrane, and this 
energy-dependent process is driven by stress-70 protein (more commonly known as 
mitochondrial heat shock protein 70; mtHsp70). Within the matrix pre-sequences are cleaved 
and nascent proteins are folded in to their mature form by the chaperonin complex, which is 
a heteroligomeric structure consisting of subunits of 60 kDa heat shock protein (chaperonin 
60; CH60) and 10 kDa heat shock protein (chaperonin 10; CH10). The crucial role of 
mitochondrial protein import is illustrated by data from yeast [58] reporting that 5 genes are 
essential for mitochondrial viability, and the products of each of these genes are components 
of the mitochondrial protein import machinery. Included in this list are chaperonin 60 and 
stress protein-70, which were significantly less abundant in LCR soleus (Table 4). In 
addition to being lethal in yeast, mutation of CH60 is related with inherited human diseases, 
including spastic paraplegia and hypomyelinating leukodystrophy [59].
It is important to mention that we detected CH60 in 5 spots and just one of these spots was 
more abundant in HCR muscle. This is consistent with our previous proteomics data [2] in 
human skeletal muscle where 3 species of CH60 were detected and one spot was 
significantly more abundant in samples collected after high-intensity interval training. As yet 
the individual CH60 species have not been characterised but it is clear that innate and 
acquired differences in muscle aerobic capacity affect proteins such as CH60 at the species 
level, in addition to reported changes in the total abundance of the protein (e.g. [60]). It 
remains to be determined whether the different species of CH60 influence the oligomeric 
structure or activity of the chaperonin complex. Similar to CH60, stress-70 protein was 
detected as a series of 3 spots, one of which (spot #53) was more abundant in HCR muscle. 
Consistent with our findings (Table 4) using artificial selection and earlier experience in 
exercise training [61], chronic low-frequency stimulation (CLFS) also increases Stress-70 
protein and CH60 [60]. In response to CLFS, the magnitude of the change in abundance of 
Stress-70 and CH60 is proportionally greater than that of respiratory chain proteins such as 
COX [60], which suggests that robust augmentation of protein import is necessary to 
facilitate mitochondrial adaptations.
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Consistent with our previous findings [11], several of the mitochondrial proteins that 
exhibited differences between HCR and LCR (Table 4) were also highlighted in the 
‘longevity interactome’ produced from genes that modify lifespan when mutated in model 
organisms such as yeast and Caenorhabditis elegans [62]. In particular, proteins involved in 
mitochondrial protein import (heat shock cognate 71, stress-70 protein and 60 kDa heat 
shock protein) fatty acid metabolism (aspartate aminotransferase) and NDRG2 belong to the 
‘core set’ of the longevity interactome, which comprises genes that also exhibit significant 
differences between muscle of young and elderly humans [62]. Therefore, our current data 
(Table 4) in young animals may link with the differences in natural ageing and life 
expectancy of HCR and LCR rats [63].
In LCR animals, serumleptin concentrations were negatively correlated with the majority of 
metabolic proteins that were differentially expressed between HCR and LCR muscle. 
Typically, leptin signalling stimulates muscle fatty acid oxidation and glucose uptake and 
improves insulin sensitivity [61]. We found that serum leptin levels were greater in males 
than females and male LCR exhibited the highest serum leptin concentrations. These 
findings extend earlier work in females [36] and the inverse correlations between serum 
leptin and the muscle proteome data suggest that LCR animals are leptin resistant.
5. Conclusion
The current work reports the first broad-scale profiling of the muscle proteome from male 
and female animals selected based on either high- or low-running capacity. Relatively few 
differences were detected between the soleus proteome of male and female animals, and sex-
specific protein regulation (Table 3) did not demonstrate strong functional clustering. In 
contrast, selection on running capacity was associated with differences in functional groups, 
such as glycolysis, TCA cycle and oxidative phosphorylation. Importantly, graphical 
network analysis of the proteome data highlighted potential interactions which were not 
obvious from first-principle deduction of the gene ontology information. The application of 
conditional independence mapping enabled us to gain insight to latent interactions, which 
may highlight underlying mechanisms. The utility of this novel unsupervised approach to 
the interpretation of DIGE data warrants wider application, and our current work also 
supports the use of bibliometric analysis as an unbiased tool for discovering potential protein 
networks. In particular, we found PDIA3 and CH60 to be key nodes associated with 
differences in muscle aerobic capacity and our data further highlight STAT3 and NDRG2 as 
novel candidate mechanisms, which may underly the differences in muscle insulin 
sensitivity.
A reference 2D gel image is available at the World 2D-PAGE repository (http://
world-2dpage.expasy.org/repository/), accession number 0069. Spot numbers used 
throughout this manuscript are consistent with the World-2DPAGE reference map and each 
spot coordinate is linked to the mass spectrometry protein identification. The associated CID 
and ETD MS/MS ions data in Mascot generic format are available upon request. 
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.jprot.
2014.04.015.
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Biological significance
Quantitative proteome profiling revealed that there is little or no sexual dimorphism in 
the skeletal muscle response to artificial selection on running capacity. Instead we found 
that noncanonical STAT3 signalling may be associated with low exercise capacity and 
skeletal muscle insulin resistance. Importantly, this discovery was made using 
unsupervised multivariate association mapping and bibliometric network analyses. This 
allowed our interpretation of the findings to be guided by patterns within the data rather 
than our preconceptions about which proteins or processes are of greatest interest. 
Moreover, we demonstrate that this novel approach can be applied to 2D gel analysis, 
which is unsurpassed in its ability to profile protein species but currently has few 
dedicated bioinformatic tools.
Burniston et al. Page 20
J Proteomics. Author manuscript; available in PMC 2015 June 25.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 1. 
DIGE reference map. Reference 2D gel map of rat soleus muscle. Annotations show the 
reference numbers of spots that were significantly different between either male vs females 
(Table 3) or high-capacity runners (HCR) vs low-capacity runners (LCR; Table 4). An 
interactive version of the gel map is available at the World-2DPAGE repository, accession 
number 0069.
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Fig. 2. 
Metabolic maps. The metabolic pathways of glycolysis, fatty acid β-oxidation and the 
tricarboxylic acid cycle are redrawn from the Kyoto Encyclopedia of Genes and Genomes 
(KEGG). For clarity the respiratory chain is not shown in its entirety, instead only subunits 
detected by DIGE are highlighted. Orange boxes display the common name of each enzyme, 
the adjacent boxes detail protein spots matched to this UniProt Rattus ID by LC–MS/MS 
analysis. A ‘heat map’ colouring system is used to display proteins that were significantly 
more abundant in HCR (green) or LCR (red) groups (Table 4).
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Fig. 3. 
Conditional independence maps of tercile and quintile associations. Conditional 
independence mapping was used to find multivariate association networks within the protein 
spots differentially expressed between HCR and LCR muscle (Table 4). Log-transformed 
continuous data of spot expression were converted to categorical terciles (A) or quintiles (B) 
to assess course- and fine-grain associations, respectively. To construct the tercile map α was 
set at 0.05, whereas more stringent (α = 0.01) testing was used in the construction of the 
quintile map. Post-hoc pair-wise testing was used to approximate the relative strength of 
associations between vertices in order to dictate edge length (shorter edge = stronger 
association) during the construction of each map. Spot numbers and protein names 
correspond with Fig. 1, Table 4 and the World-2DPAGE database (accession #0069).
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Fig. 4. 
Bibliometric network of PDIA3. A gene model representing the bibliometric network of 
PDIA3 was constructed by automated text-mining (data redrawn from iHOP; information 
hyperlinked over proteins; www.ihop-net. org). Nodes (genes) are connected by edges, 
which represent co-occurrence within sentences of peer-reviewed published literature. Edge 
thickness approximates the number of supporting sentences. The majority of associations 
(CANX, calnexin; CALR, calreticulin, TAPBP, tapsin; HLA-E/HLA-C, major 
histocompatibility complex IE/C; HSPA5, glucose regulated protein 78; P4HB, prolyl-4-
hydroxylase beta) were related to protein folding or assembly of protein complexes within 
the endoplasmic reticulum. PDIA3 was also reported to interact (TUBB3, class III beta 
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tubulin) or be co-expressed with mitogen activated protein kinase kinase kinase 5 
(MAP3K5) and gene differentially expressed in prostate (GDEP) in malignant stages of 
prostate cancer. Fourteen sentences reported interaction or colocalisation of PDIA3 with 
STAT3.
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Fig. 5. 
STAT3 phosphorylation in male and female HCR/LCR muscle. STAT3 protein abundance 
and relative phosphorylation of either tyrosine (Y705) or serine (S727) residues was 
measured in the solei of male and female, HCR and LCR animals (A). Two-way analysis of 
variance found no significant difference in the abundance of STAT3 (B) or in the relative 
amount of Y705 phosphorylation (C). In contrast, a significant (*P < 0.05) main effect of 
‘strain’ (i.e. HCR vs LCR) was evident for S727 phosphorylation. On average, the extent of 
S727 phosphorylation was 1.54-fold greater in LCR soleus (D).
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